4401 - 4410 of 9131 Results
Title
Year
-
OPENTitle: Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 TrialsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1663End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212672Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212672?id=journal-of-parkinsons-disease%2Fjpd212672Citation Count: 42
-
OPENTitle: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 557End Page: 570Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212714Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212714?id=journal-of-parkinsons-disease%2Fjpd212714Citation Count: 61
-
OPENTitle: The effect of deep brain stimulation randomized by site on balance in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 7Start Page: 949End Page: 953Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25831Best OA location URL: http://doi.org/10.1002/mds.25831Citation Count: 53
-
OPENTitle: The relationship between obsessive‐compulsive symptoms and PARKIN genotype: The CORE‐PD studyJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 2Start Page: 278End Page: 283Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26065Best OA location URL: http://doi.org/10.1002/mds.26065Citation Count: 19
-
OPENTitle: Clinical markers for identifying cholinergic deficits in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 2Start Page: 269End Page: 273Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26061Best OA location URL: https://hdl.handle.net/2027.42/110743Citation Count: 63
-
OPENTitle: Solution-Phase Parallel Synthesis and SAR of Homopiperazinyl Analogs as Positive Allosteric Modulators of mGlu4Journal Name: ACS Combinatorial SciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 2Start Page: 159End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/co1000508Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3057427Citation Count: 8
- Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations2015OPENTitle: Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutationsJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 904End Page: 908Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26250Best OA location URL: http://doi.org/10.1002/mds.26250Citation Count: 12
-
OPENTitle: Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 129Issue #: 4Start Page: 565End Page: 583Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-015-1395-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-015-1395-2.pdfCitation Count: 56
-
OPENTitle: Structural alterations of the intestinal epithelial barrier in Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page: 12End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-015-0196-0Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-015-0196-0Citation Count: 294
-
OPENTitle: Endpoints and Analyses to Discern Disease-Modifying Drug Effects in Early Parkinson’s DiseaseJournal Name: The AAPS JournalPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 456End Page: 64Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1208/s12248-009-9123-2Best OA location URL: https://link.springer.com/content/pdf/10.1208/s12248-009-9123-2.pdfCitation Count: 68